Two years of continued early treatment for recent-onset schizophrenia: A randomised controlled study

Acta Psychiatrica Scandinavica

Volumn 114, Issue 5, 2006, Pages 328-336

  Grawe, R W ^a   Falloon, I R H ^b,c   Widen, J H ^d   Skogvoll, E ^e  

^a SINTEF   (Norway)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d Telemark Hospital   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Clinical outcome; Early intervention; Randomised controlled trial; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; BRIEF PSYCHIATRIC RATING SCALE; CASE MANAGEMENT; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; EVIDENCE BASED PRACTICE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HOME CARE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SKILL; SOCIAL PSYCHOLOGY; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TRAINING;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CONTINUITY OF PATIENT CARE; CRISIS INTERVENTION; DELIVERY OF HEALTH CARE, INTEGRATED; DRUG THERAPY; FEMALE; HUMANS; MALE; RECURRENCE; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 33749460245     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2006.00799.x     Document Type: Article

References (51)

1. CRAIG TK, GARETY P, POWER P et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 2004;329:1067.
2. LINSZEN D, DINGEMANS P, LENIOR M. Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications. Schizophr Res 2001;51:55-61.
3. MCGORRY PD, YUNG AR, PHILLIPS LJ et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiat 2002;59:921-928.
4. BREIER A, SCHREIBER JL, DYER J, PICKAR D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiat 1991;48:239.
5. CROW TJ, MACMILLAN JF, JOHNSON AL, JOHNSTONE EC. The Northwick Park study of first episodes of schizophrenia. II. A randomised controlled trial of prophylactic neuroleptic treatment. Brit J Psychiat 1986;148:120-127.
6. HADDOCK G, TARRIER N, MORRISON AP et al. A pilot study evaluating the effectiveness of individual in-patient cognitive-behavioural therapy in early psychosis. Soc Psych Psych Epid 1999;34:254-258.
7. JACKSON H, MCGORRY P, HENRY L et al. Cognitively oriented psychotherapy for early psychosis (COPE): a 1-year follow-up. Brit J Clin Psychol 2001;40:57-70.
8. LINSZEN D, DINGEMANS P, VAN DER DOES JW et al. Treatment, expressed emotion and relapse in recent onset schizophrenic disorders. Psychol Med 1996;26:333-342.
9. MORRISON AP, FRENCH P, WALFORD L et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004;185:291-297.
10. CULLBERG J, LEVANDER S, HOLMQUIST R, MATTSSON M, WIESELGRAN I-M. One year outcome in first episode psychosis in the Swedish Parachute project. Acta Psychiatr Scand 2002;106:276-285.
11. FALLOON IRH. Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry 1992;55:4-15.
12. Malla AK, Norman RM, Manchanda R et al. Status of patients with first-episode psychosis after one year of phasespecific community-oriented treatment. Psychiat Serv 2002;53:458-63.
13. MCGORRY PD, EDWARDS J, MIHALOPOULOS C et al. EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bull 1996;22:305-326.
14. PETERSEN L, NORDENTOFT M, JEPPESEN P et al. Improving 1-year outcome in first epuisode psychosis. OPUS trial. Br J Psychiatry Suppl 2005;187:s48, 98-104.
15. FALLON IRH, HELD T, RONCONE R, COVERDALE JH et al. Optimal treatment strategies to enhance recovery from schizophrenia. ANZ J Psychiatry 1998;32:43-49.
16. KOPELOWICZ A, LIBERMAN RP. Integrating treatment with rehabilitation for persons with major mental illnesses. Psychiat Serv 2003;54:1491-1498.
17. WYATT RJ. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bull 1991;17:325-351.
18. FALLOON IRH. Family interventions of mental disorders: efficacy and effectiveness. World Psychiat 2003;2:20-28.
19. PILLING S, BEBBINGTON P, KUIPERS E et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002;32:763-82.
20. LEHMAN AF, STEINWACHS DM. Translating research into practice. The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bull 1998;24:1-10.
21. LEHMAN AF, LIEBERMAN JA, DIXON LB et al. American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiat 2004;161(suppl):1-56.
22. National Institute for Clinical Excellence, NICE. Clinical Guideline 1: Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. London: NICE, 2003.
23. THORNICROFT G, SUSSER E. Evidence-based psychotherapeutic interventions in the community care of schizophrenia. Brit J Psychiat 2001;178:2-4.
24. FALLOON IRH. and Associates. Family Management of Schizophrenia: Clinical, Social, Family and Economic Benefits. Baltimore: Johns Hopkins University Press, 1985.
25. FALLOON IRH, MONTERO I, SUNGUR M et al. Implementation of Evidence-Based Treatment for Schizophrenic Disorders: two-year outcome of an international field trial of optimal treatment. World Psychiat 2004;3:104-109.
26. FALLOON IRH. and The Optimal Treatment Project Collaborators. Optimal treatment for psychosis in an International Multisite Demonstration Project. Psychiat Serv 1999;50:615-618.
27. FALLOON IRH, FADDEN G. Integrated mental health care. Cambridge: Cambridge University Press, 1993.
28. FALLOON IRH and O.T.P. collaborators. Integrated Mental Health Care - a Guidebook for Consumers. Perugia.: Optimal Treatment Project, ARIETE, 2001.
29. LEHMAN AF, BUCHANAN RW, DICKERSON FB et al.. Evidence-based treatment for schizophrenia. Psychiatric Clinics of North America 2003;26:939-954.
30. American Psychiatric Association, APA. Practice Guideline for Treatment of patients with Schizophrenia. Am J Psychiat 1997;154(suppl. 4).
31. BUSTILLO J, LAURIELLO J, HORAN W et al. The psychosocial treatment of schizophrenia: and update. Am J Psychiat 2001;158:163-175.
32. MUESER KT, TORREY WC, LYNDE D et al. Implementing evidence-based practices for people with severe mental illness. Behav Modif 2003;27:387-411.
33. KANE JM, MCGLASHAN TH. Treatment of schizophrenia. Lancet 1995;346:820-825.
34. FALLOON IRH, ECONOMOU M, PALLI A et al. A standardised measure for verifying the quality of treatment and care in mental health services: The Clinical Strategies Implementation Scale. Psychiatr Serv 2005;56:1584-1590.
35. FALLOON IRH, BOYD JL, MCGILL CW et al. Family management in the prevention of exacerbations of schizophrenia: a controlled study. New Engl J Med 1982;306:1437-1440.
36. VENTURA J, GREEN MF, SHANER A et al. Training and quality assurance with the Brief Psychiatric Rating Scale: 'The drift busters". Int J Meth Psych Res 1993;3:221-244.
37. VENTURA J, NUECHTERLEIN KH, SUBOTNIK KL et al. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiat Res 2000;97:129-135.
38. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1993.
39. NUECHTERLEIN KH, DAWSON ME, GITLIN M. et al. Developmental Processes in Schizophrenic Disorders: Longitudinal studies of vulnerability and Stress. Schizophrenia Bull 1992;18:387-425.
40. HAUSCHKE D, STEINIJANS WV, DILETTI E et al. Presentation of the intra-subject coefficient of variation for sample size planning in bioequivalence studies. Int J Clin Pharmacol Ther 1994;32:376-378.
41. ROBINSON D, WOERNER MG, ALVIR JM et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiat 1999;56:241-247.
42. The Scottish Schizophrenia Research Group. The Scottish first episode schizophrenia study. VIII. Five-year followup: clinical and psychosocial findings. Brit J Psychiat 1992;161:496-500.
43. SHEPHERD M, WATT DC, FALLOON IRH et al. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychological Medicine Monograph, 15, Cambridge: Cambridge University Press, 1989.
44. SVEDBERG B, MESTERTON A, CULLBERG J. First-episode nonaffective psychosis in a total urban population: a 5-year follow-up. Soc Psychiat & Psychiat Epidemiol 2001;36:332-337.
45. WIERSMA D, NIENHUIS FJ, SLOOFF CJ et al. Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophrenia Bull 1998;24:75-85.
46. RESNICK SG, ROSENHECK RA, LEHMAN AF. An exploratory analysis of correlates of recovery. Psychiat Serv 2004;55:540-547.
47. MANCHANDA R, NORMAN R, MALLA A, HARRICHARAN R, TAKHAR J, NORTHCOTT S. EEG abnormalities and two year outcome in first episode psychosis. Acta Psychiat Scand 2005;111:208-13.
48. COLDHAM EL, ADDINGTON J, ADDINGTON D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiat Scand 2002;106:286-90.
49. KANE JM, MARDER SR. Psychopharmacologic treatment of schizophrenia. Schizophrenia Bull 1993;19:287-302.
50. SCHOOLER NR. Maintenance medication for schizophrenia. Schizophrenia Bull 1991;17:311-324.
51. FALLOON IRH. Antipsychotic drugs: When and how to withdraw them? Psychosomatics and Psychotherapy, in press.